| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $267.6M | +23.1% |
| SG&A Expense | $73.8M | +48.4% |
| Operating Income | -$341.4M | -27.8% |
| Interest Expense | $18K | -18.2% |
| Pre-tax Income | $333.8M | +225.1% |
| Income Tax | $33K | -55.4% |
| Net Income | -$333.8M | -25.0% |
| EPS (Basic) | -$6.39 | -23.8% |
| EPS (Diluted) | -$6.39 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $190.4M | -74.0% |
| Short-term Investments | $288.5M | — |
| Current Assets | $486.0M | -33.9% |
| Total Assets | $666.6M | -26.3% |
| Current Liabilities | $52.5M | -18.8% |
| Total Liabilities | $230.5M | -4.3% |
| Stockholders' Equity | $436.2M | -34.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$206.5M | -13.3% |
| Capital Expenditures | $37.0M | +117.4% |
| Investing Cash Flow | -$336.5M | -767.3% |
| Financing Cash Flow | $1.9M | -76.8% |
| Free Cash Flow | -$243.5M | -22.2% |
| -23.8% |